Information
| Unit | FACULTY OF PHARMACY |
| PHARMACY PR. | |
| Code | ECS537 |
| Name | Drug Carrier Particulate Systems |
| Term | 2021-2022 Academic Year |
| Semester | 9. Semester |
| Duration (T+A) | 2-0 (T-A) (17 Week) |
| ECTS | 3 ECTS |
| National Credit | 2 National Credit |
| Teaching Language | Türkçe |
| Level | Lisans Dersi |
| Type | Normal |
| Label | E Elective |
| Mode of study | Uzaktan Öğretim |
| Catalog Information Coordinator | Dr. Öğr. Üyesi ESRA DEMİRTÜRK |
| Course Instructor |
Dr. Öğr. Üyesi ESRA DEMİRTÜRK
(Güz)
(A Group)
(Ins. in Charge)
Doç. Dr. UMAY MERVE GÜVEN BÖLGEN (Güz) (A Group) (Asst. Ins.) |
Course Goal / Objective
It is aimed to introduce students to modern particulate therapeutic systems, the ways of drug use and the reasons for the development of these systems, and the importance of biopolymers in modern particulate therapeutic system design.
Course Content
It includes detailed information on the features and importance of micro and nanoparticular systems, micro and nanoparticular systems, their production and characterization.
Course Precondition
Resources
Notes
Course Learning Outcomes
| Order | Course Learning Outcomes |
|---|---|
| LO01 | Define Drug Carrier Particulate Systems. |
| LO02 | Categorize Drug Carrier Particulate Systems. |
| LO03 | Defines polymers used in Drug Carrier Particulate Systems. |
| LO04 | Knows the working mechanisms of polymers used in Drug Carrier Particulate Systems. |
| LO05 | List the characterizations made in Drug Carrier Particulate Systems. |
| LO06 | Describes the stability studies performed in Drug Carrier Particulate Systems. |
Relation with Program Learning Outcome
| Order | Type | Program Learning Outcomes | Level |
|---|---|---|---|
| PLO01 | Bilgi - Kuramsal, Olgusal | Have sufficient knowledge in pharmaceutical field and develop the knowledge. | 3 |
| PLO02 | Bilgi - Kuramsal, Olgusal | Comprehends professional knowledge with ethical responsibility through current laws and legislation. | |
| PLO03 | Beceriler - Bilişsel, Uygulamalı | Provides consultancy service to patients, community and health care personnel and evaluates advanced knowledge and skills with a critical approach. | 3 |
| PLO04 | Beceriler - Bilişsel, Uygulamalı | Possessing the knowledge of historical and current developments in the field of Pharmacy, monitoring, evaluation and application of scientific and evidence-based data, and adopting lifelong learning. | |
| PLO05 | Beceriler - Bilişsel, Uygulamalı | Have the knowledge and skills to help provide patient-oriented pharmacy applications and individualized pharmaceutical care by learning the basics of Clinical Pharmacy, | |
| PLO06 | Yetkinlikler - Bağımsız Çalışabilme ve Sorumluluk Alabilme Yetkinliği | Takes a role in the evaluation and analysis of the events and cases related to the development of pharmacy profession and education. | 2 |
| PLO07 | Yetkinlikler - Öğrenme Yetkinliği | Integrates and develops professional knowledge via different disciplines and uses the acquired knowledge to improve the health level and quality of life of the community. | 1 |
| PLO08 | Yetkinlikler - Öğrenme Yetkinliği | Use effectively the concepts and applications of basic sciences and basic medical sciences in the field of medicine and pharmacy and update the information. | |
| PLO09 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Communicates effectively in writing and speaking. | |
| PLO10 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Practices the profession in accordance with Atatürk's principles and reforms, equipped with universal knowledge, uses Turkish correctly and knows at least one foreign language. | |
| PLO11 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Be an example to society withexternal appearance, demeanor, attitude and behavior for the other professionals and society and with professional identity | |
| PLO12 | Yetkinlikler - Alana Özgü Yetkinlik | Have knowledge about health policies and health economics, pharmacy management and define the problems in pharmaceutical field. | |
| PLO13 | Yetkinlikler - Alana Özgü Yetkinlik | Interprets information about current health and treatment problems and attends meeting on related matters . Plays an active role in community health. | 2 |
| PLO14 | Yetkinlikler - Alana Özgü Yetkinlik | Acquires basic information about diseases, makes decisions about the drugs used in treatment in accordance with rational drug use. |
Week Plan
| Week | Topic | Preparation | Methods |
|---|---|---|---|
| 1 | Defining Drug Carrier Particulate Systems | Research | |
| 2 | Classification of Drug Delivery Particulate Systems | Research | |
| 3 | Polymers | Research | |
| 4 | Polymers | Research | |
| 5 | Polymeric Nanoparticles | Research | |
| 6 | Solid Lipid Particles | Research | |
| 7 | Microspheres | Research | |
| 8 | Mid-Term Exam | Exam | |
| 9 | Vesicular systems | Research | |
| 10 | Systems Applied to the Lung | Research | |
| 11 | Particulate Systems Used in Cancer Treatment | Research | |
| 12 | New Drug Delivery Systems | Research | |
| 13 | Targeted Drug Delivery Systems | Research | |
| 14 | Characterization in particulate systems | Research | |
| 15 | Stability in particulate systems | Research | |
| 16 | Term Exams | Exam | |
| 17 | Term Exams | Exam |
Assessment (Exam) Methods and Criteria
| Assessment Type | Midterm / Year Impact | End of Term / End of Year Impact |
|---|---|---|
| 1. Midterm Exam | 100 | 40 |
| General Assessment | ||
| Midterm / Year Total | 100 | 40 |
| 1. Final Exam | - | 60 |
| Grand Total | - | 100 |
Student Workload - ECTS
| Works | Number | Time (Hour) | Workload (Hour) |
|---|---|---|---|
| Course Related Works | |||
| Class Time (Exam weeks are excluded) | 14 | 2 | 28 |
| Out of Class Study (Preliminary Work, Practice) | 14 | 2 | 28 |
| Assesment Related Works | |||
| Homeworks, Projects, Others | 0 | 0 | 0 |
| Mid-term Exams (Written, Oral, etc.) | 1 | 6 | 6 |
| Final Exam | 1 | 16 | 16 |
| Total Workload (Hour) | 78 | ||
| Total Workload / 25 (h) | 3,12 | ||
| ECTS | 3 ECTS | ||